Please assess the completion status of the following clinical trial:

Trial Title: Effects of Added D-fagomine on Glycaemic Responses to Sucrose

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female (not less than 40% Male)~* Aged 18 - 55 years~* Have a body mass index between 18.5 to 29.99 kg/m2~* Healthy, non-diabetic, no gastric bypass surgery~* Have a fasting plasma glucose (finger-stick) \<100 mg/dl (\<5.5 mmol/L)~* Willing and able to provide written informed consent~Exclusion Criteria:~* Smokers~* Allergic to dairy or soy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- D-fagomine (Type: EXPERIMENTAL): Measure the changes produced on the postprandial Glycaemic response to 50 g of sucrose containing 40 mg D-fagomine, in 200 ml water
- Control (Type: PLACEBO_COMPARATOR): Sucrose 50 g without d-fagomine, in 200 ml water

Based on this trial design, predict the completion outcome and termination type (if applicable).